BELEMSI Trademark

Trademark Overview


On Friday, December 17, 2021, a trademark application was filed for BELEMSI with the United States Patent and Trademark Office. The USPTO has given the BELEMSI trademark a serial number of 79332046. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by NOVARTIS AG. The BELEMSI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
belemsi

General Information


Serial Number79332046
Word MarkBELEMSI
Filing DateFriday, December 17, 2021
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7209332
Registration DateTuesday, November 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events


Event DateEvent Description
Saturday, November 11, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Monday, November 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 1, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, November 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 1, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 1, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 14, 2023PETITION TO DIRECTOR DISMISSED
Friday, July 14, 2023NOTICE OF REINSTATEMENT E-MAILED
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, July 11, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023REINSTATED
Thursday, May 25, 2023ASSIGNED TO PETITION STAFF
Friday, February 3, 2023TEAS PETITION TO DIRECTOR RECEIVED
Monday, February 21, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, February 20, 2022DEATH OF INTERNATIONAL REGISTRATION
Tuesday, February 15, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 2, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 27, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB